The ACP received funding to help interpret research and support decisions about MS treatments for older adults with MS.
Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...
In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...
RMAT designation is based on promising Phase 2 clinical data demonstrating NG01’s potential to reduce disability and ...
HOUSTON and WALTHAM, Mass., April 17, 2025 /PRNewswire/ -- Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated ...
Multiple sclerosis, or MS, is a disease that causes the immune system to attack the protective sheath that covers nerve fibers. Symptoms and severity of the disease vary from person to person. In some ...
Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results